K. Shalini, “To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus”, IJRPLS, vol. 12, no. 02, pp. 31–37, Aug. 2024, doi: 10.30904/j.ijrpls.2024.4722.